12 | Infusion Brands International Forges Global | Mr Green Genes | 03/30/2012 12:06:03 AM |
11 | INBI Looking really good @ .089 These | Mr Green Genes | 03/28/2012 1:31:29 PM |
10 | Likewise bro! We are! And to think, if 4th Q 2011 | GHOST | 03/28/2012 5:50:09 AM |
9 | INBI I'm in it for the long haul.. I'd like | Mr Green Genes | 03/28/2012 1:36:25 AM |
8 | Recent Company News: | GHOST | 03/28/2012 12:47:10 AM |
7 | A very important read: "Brand Up" Article dated: | GHOST | 03/28/2012 12:46:37 AM |
6 | Very solid IMO. I will be here for a very, very | GHOST | 03/28/2012 12:31:34 AM |
5 | Vicis Capital Master Fund (A Hedge Fund in New | GHOST | 03/28/2012 12:19:35 AM |
4 | Business Description: Infusion Brands | GHOST | 03/28/2012 12:17:40 AM |
3 | Website: | GHOST | 03/28/2012 12:17:27 AM |
2 | INBI looking really good The DD here is | Mr Green Genes | 03/27/2012 9:05:07 PM |
1 | INBI is a Hidden Gem now discovered. DD | GHOST | 03/27/2012 6:50:35 PM |
Recent Articles
- Exciting Growth Ahead for Global Ceramics Market By 2030
- M4Markets Strengthens Ties with Alpine Team in Endurance Racing
- Enhancing Cyber Security with Tailored Phishing Recovery Solutions
- Investigation Into Goshen Medical Center Data Breach Claims
- Radware Reveals Groundbreaking Zero-Click Vulnerability Impacting ChatGPT
- Gettanginow Corporation Launches Compliant Cannabis Payment System
- Onex Partners Expands Investment in Innovative Insurance Solutions
- MD Capital's Financing Preserves Over 700 Jobs with AI Support
- A Comprehensive Analysis of MFA Financial Inc. Stock Trends
- Bullish Options Trading Insights for Rivian Automotive
- Exploring Netflix's Emerging Trends in Options Trading
- Bullish Movements in First Solar Options Activity Unveiled
- Wheat and Soybean Markets: Adapting to Changing Dynamics
- Sunstone Winery Unveils SOLIS™: A New Era in Beverages
- Spa Medicca Expands Network with Skin Science Partnership
- Bespoke Home Education Solutions for Elite Families Seeking Guidance
- Citadel EHS Strengthens Presence in Pacific Northwest Market
- Enhancing Cybersecurity Awareness in Class Action Law
- Revolutionizing Flood Prediction with AI Insights and Tools
- Rigetti Computing's Recent Contract Boosts Stock Performance
- DocGo Inc. Faces Legal Scrutiny Amid Allegations of Misconduct
- Ongoing Inquiry into Driven Brands: Insight and Impact
- Exclusive Supercars to Shine at Broad Arrow's Zoute Auction
- Continued Investigation into Virtu Financial's Leadership and Practices
- Milesight and Vemco Forge Alliance for Advanced IoT Solutions
- Ongoing Investigation into NAPCO Security Technologies Leadership
- Continued Investigation into iRhythm Technologies' Management by KSF
- Understanding Gen Z's Shift to Side Hustles Over Traditional Jobs
- Understanding Alto Neuroscience's Current Legal Situation
- Investigation Launched into D-Wave Quantum Inc. Details
- DraftKings Faces Pressure Amid Emerging Competitors in Betting
- LifeMD, Inc. Under Investigation: What Investors Need to Know
- Inmar Intelligence Secures Major Agreements with Premier, Inc.
- Argosy Private Equity's Strategic Growth through Groome Exit
- Insta360 Earns Emmy® for Groundbreaking 360 Camera Innovations
- Katie Johnson's Inspiring Journey Through Infertility
- Formation Bio Enhances Leadership for Accelerated Drug Innovations
- Transforming After Divorce: Finding Your New Path
- Quadient Shines as AI Innovation Leader in Communications Sector
- General Mills Achieves Strong Q1 Earnings and Stock Growth
- Understanding Recent Shifts in Entergy's Market Sentiment
- Understanding Short Interests: The Taysha Gene Therapies Insight
- Exploring Recent Shifts in Performance Food Group's Market Sentiment
- Hamilton Lane Inc. Optimizes Wealth Strategy for Growth
- Tech Stocks Surge as Small Caps Lead Market Gains Today
- LabConnect Welcomes Bill Finger as Senior VP for Global Services
- Celebration of Culture: Qatar Philharmonic Orchestra's Journey
- Milesight and Vemco Group's Game-Changing Collaboration
- GE Aerospace Declares Consistent Dividend for Shareholders
- Immix Biopharma Achieves Milestone in AL Amyloidosis Trial